PAUL S COVINGTON Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for PAUL S COVINGTON.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of PAUL S COVINGTON. PAUL S COVINGTON is Executive Vice President in PHARMACEUTICAL PRODUCT DEVELOPMENT INC ($PPDI).
Latest Insider Trading Transactions of PAUL S COVINGTON
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 08 2008 | PPDI | PHARMACEUTICAL PRO ... | COVINGTON PAUL S | Executive Vice Pres ... | Buy | I | 36.33 | 619 | 22,488 | 881 | 262 to 881 (+236.26 %) |
| Feb 29 2008 | PPDI | PHARMACEUTICAL PRO ... | COVINGTON PAUL S | Executive Vice Pres ... | Sell | S | 47.09 | 200 | 9,418 | 262 | 462 to 262 (-43.29 %) |
| Feb 29 2008 | PPDI | PHARMACEUTICAL PRO ... | COVINGTON PAUL S | Executive Vice Pres ... | Sell | S | 47.08 | 1,300 | 61,204 | 462 | 1.8 K to 462 (-73.78 %) |
| Feb 29 2008 | PPDI | PHARMACEUTICAL PRO ... | COVINGTON PAUL S | Executive Vice Pres ... | Sell | S | 47.07 | 400 | 18,828 | 1,762 | 2.2 K to 1.8 K (-18.50 %) |
| Feb 29 2008 | PPDI | PHARMACEUTICAL PRO ... | COVINGTON PAUL S | Executive Vice Pres ... | Sell | S | 47.05 | 2,200 | 103,510 | 2,162 | 4.4 K to 2.2 K (-50.44 %) |
| Feb 29 2008 | PPDI | PHARMACEUTICAL PRO ... | COVINGTON PAUL S | Executive Vice Pres ... | Sell | S | 46.96 | 100 | 4,696 | 4,362 | 4.5 K to 4.4 K (-2.24 %) |
| Feb 29 2008 | PPDI | PHARMACEUTICAL PRO ... | COVINGTON PAUL S | Executive Vice Pres ... | Sell | S | 46.91 | 200 | 9,382 | 4,462 | 4.7 K to 4.5 K (-4.29 %) |
| Feb 29 2008 | PPDI | PHARMACEUTICAL PRO ... | COVINGTON PAUL S | Executive Vice Pres ... | Sell | S | 46.90 | 4,200 | 196,980 | 4,662 | 8.9 K to 4.7 K (-47.39 %) |
| Feb 29 2008 | PPDI | PHARMACEUTICAL PRO ... | COVINGTON PAUL S | Executive Vice Pres ... | Sell | S | 46.85 | 200 | 9,370 | 8,862 | 9.1 K to 8.9 K (-2.21 %) |
| Feb 29 2008 | PPDI | PHARMACEUTICAL PRO ... | COVINGTON PAUL S | Executive Vice Pres ... | Sell | S | 46.84 | 100 | 4,684 | 9,062 | 9.2 K to 9.1 K (-1.09 %) |
| Feb 29 2008 | PPDI | PHARMACEUTICAL PRO ... | COVINGTON PAUL S | Executive Vice Pres ... | Sell | S | 46.82 | 100 | 4,682 | 9,162 | 9.3 K to 9.2 K (-1.08 %) |
| Feb 29 2008 | PPDI | PHARMACEUTICAL PRO ... | COVINGTON PAUL S | Executive Vice Pres ... | Sell | S | 46.78 | 400 | 18,712 | 9,262 | 9.7 K to 9.3 K (-4.14 %) |
| Feb 29 2008 | PPDI | PHARMACEUTICAL PRO ... | COVINGTON PAUL S | Executive Vice Pres ... | Sell | S | 46.77 | 500 | 23,385 | 9,662 | 10.2 K to 9.7 K (-4.92 %) |
| Feb 29 2008 | PPDI | PHARMACEUTICAL PRO ... | COVINGTON PAUL S | Executive Vice Pres ... | Sell | S | 46.75 | 100 | 4,675 | 10,162 | 10.3 K to 10.2 K (-0.97 %) |
| Feb 29 2008 | PPDI | PHARMACEUTICAL PRO ... | COVINGTON PAUL S | Executive Vice Pres ... | Sell | S | 47.05 | 196 | 9,222 | 10,262 | 10.5 K to 10.3 K (-1.87 %) |
| Feb 29 2008 | PPDI | PHARMACEUTICAL PRO ... | COVINGTON PAUL S | Executive Vice Pres ... | Option Exercise | M | 34.62 | 26,666 | 923,177 | 13,334 | |
| Feb 29 2008 | PPDI | PHARMACEUTICAL PRO ... | COVINGTON PAUL S | Executive Vice Pres ... | Option Exercise | M | 33.61 | 10,000 | 336,100 | 20,000 | |
| Feb 29 2008 | PPDI | PHARMACEUTICAL PRO ... | COVINGTON PAUL S | Executive Vice Pres ... | Sell | S | 47.05 | 100 | 4,705 | 11,058 | 11.2 K to 11.1 K (-0.90 %) |
| Feb 29 2008 | PPDI | PHARMACEUTICAL PRO ... | COVINGTON PAUL S | Executive Vice Pres ... | Sell | S | 47.00 | 100 | 4,700 | 11,158 | 11.3 K to 11.2 K (-0.89 %) |
| Feb 29 2008 | PPDI | PHARMACEUTICAL PRO ... | COVINGTON PAUL S | Executive Vice Pres ... | Sell | S | 46.98 | 1,666 | 78,269 | 11,258 | 12.9 K to 11.3 K (-12.89 %) |
| Feb 29 2008 | PPDI | PHARMACEUTICAL PRO ... | COVINGTON PAUL S | Executive Vice Pres ... | Sell | S | 46.97 | 369 | 17,332 | 12,924 | 13.3 K to 12.9 K (-2.78 %) |
| Feb 29 2008 | PPDI | PHARMACEUTICAL PRO ... | COVINGTON PAUL S | Executive Vice Pres ... | Sell | S | 46.95 | 645 | 30,283 | 13,293 | 13.9 K to 13.3 K (-4.63 %) |
| Feb 29 2008 | PPDI | PHARMACEUTICAL PRO ... | COVINGTON PAUL S | Executive Vice Pres ... | Sell | S | 46.94 | 300 | 14,082 | 13,938 | 14.2 K to 13.9 K (-2.11 %) |
| Feb 29 2008 | PPDI | PHARMACEUTICAL PRO ... | COVINGTON PAUL S | Executive Vice Pres ... | Sell | S | 46.93 | 900 | 42,237 | 13,638 | 14.5 K to 13.6 K (-6.19 %) |
| Feb 29 2008 | PPDI | PHARMACEUTICAL PRO ... | COVINGTON PAUL S | Executive Vice Pres ... | Sell | S | 46.92 | 888 | 41,665 | 14,538 | 15.4 K to 14.5 K (-5.76 %) |
| Feb 29 2008 | PPDI | PHARMACEUTICAL PRO ... | COVINGTON PAUL S | Executive Vice Pres ... | Sell | S | 46.91 | 631 | 29,600 | 15,426 | 16.1 K to 15.4 K (-3.93 %) |
| Feb 29 2008 | PPDI | PHARMACEUTICAL PRO ... | COVINGTON PAUL S | Executive Vice Pres ... | Sell | S | 46.90 | 3,955 | 185,490 | 16,057 | 20 K to 16.1 K (-19.76 %) |
| Feb 29 2008 | PPDI | PHARMACEUTICAL PRO ... | COVINGTON PAUL S | Executive Vice Pres ... | Sell | S | 46.89 | 1,300 | 60,957 | 20,012 | 21.3 K to 20 K (-6.10 %) |
| Feb 29 2008 | PPDI | PHARMACEUTICAL PRO ... | COVINGTON PAUL S | Executive Vice Pres ... | Sell | S | 46.88 | 2,300 | 107,824 | 21,312 | 23.6 K to 21.3 K (-9.74 %) |
| Feb 29 2008 | PPDI | PHARMACEUTICAL PRO ... | COVINGTON PAUL S | Executive Vice Pres ... | Sell | S | 46.87 | 1,600 | 74,992 | 23,612 | 25.2 K to 23.6 K (-6.35 %) |
| Feb 29 2008 | PPDI | PHARMACEUTICAL PRO ... | COVINGTON PAUL S | Executive Vice Pres ... | Sell | S | 46.86 | 1,000 | 46,860 | 25,212 | 26.2 K to 25.2 K (-3.82 %) |
| Feb 29 2008 | PPDI | PHARMACEUTICAL PRO ... | COVINGTON PAUL S | Executive Vice Pres ... | Sell | S | 46.85 | 1,800 | 84,330 | 26,212 | 28 K to 26.2 K (-6.43 %) |
| Feb 29 2008 | PPDI | PHARMACEUTICAL PRO ... | COVINGTON PAUL S | Executive Vice Pres ... | Sell | S | 46.84 | 1,100 | 51,524 | 28,012 | 29.1 K to 28 K (-3.78 %) |
| Feb 29 2008 | PPDI | PHARMACEUTICAL PRO ... | COVINGTON PAUL S | Executive Vice Pres ... | Sell | S | 46.82 | 200 | 9,364 | 29,112 | 29.3 K to 29.1 K (-0.68 %) |
| Feb 29 2008 | PPDI | PHARMACEUTICAL PRO ... | COVINGTON PAUL S | Executive Vice Pres ... | Sell | S | 46.81 | 100 | 4,681 | 29,312 | 29.4 K to 29.3 K (-0.34 %) |
| Feb 29 2008 | PPDI | PHARMACEUTICAL PRO ... | COVINGTON PAUL S | Executive Vice Pres ... | Sell | S | 46.80 | 700 | 32,760 | 29,412 | 30.1 K to 29.4 K (-2.32 %) |
| Feb 29 2008 | PPDI | PHARMACEUTICAL PRO ... | COVINGTON PAUL S | Executive Vice Pres ... | Sell | S | 46.79 | 36 | 1,684 | 30,112 | 30.1 K to 30.1 K (-0.12 %) |
| Feb 29 2008 | PPDI | PHARMACEUTICAL PRO ... | COVINGTON PAUL S | Executive Vice Pres ... | Sell | S | 46.78 | 64 | 2,994 | 30,148 | 30.2 K to 30.1 K (-0.21 %) |
| Feb 29 2008 | PPDI | PHARMACEUTICAL PRO ... | COVINGTON PAUL S | Executive Vice Pres ... | Sell | S | 46.73 | 100 | 4,673 | 30,212 | 30.3 K to 30.2 K (-0.33 %) |
| Feb 29 2008 | PPDI | PHARMACEUTICAL PRO ... | COVINGTON PAUL S | Executive Vice Pres ... | Sell | S | 46.71 | 200 | 9,342 | 30,312 | 30.5 K to 30.3 K (-0.66 %) |
| Feb 29 2008 | PPDI | PHARMACEUTICAL PRO ... | COVINGTON PAUL S | Executive Vice Pres ... | Sell | S | 46.69 | 500 | 23,345 | 30,512 | 31 K to 30.5 K (-1.61 %) |
| Feb 29 2008 | PPDI | PHARMACEUTICAL PRO ... | COVINGTON PAUL S | Executive Vice Pres ... | Sell | S | 46.68 | 800 | 37,344 | 31,012 | 31.8 K to 31 K (-2.51 %) |
| Feb 29 2008 | PPDI | PHARMACEUTICAL PRO ... | COVINGTON PAUL S | Executive Vice Pres ... | Sell | S | 46.67 | 3,216 | 150,091 | 31,812 | 35 K to 31.8 K (-9.18 %) |
| Feb 29 2008 | PPDI | PHARMACEUTICAL PRO ... | COVINGTON PAUL S | Executive Vice Pres ... | Sell | S | 46.64 | 100 | 4,664 | 35,028 | 35.1 K to 35 K (-0.28 %) |
| Feb 29 2008 | PPDI | PHARMACEUTICAL PRO ... | COVINGTON PAUL S | Executive Vice Pres ... | Sell | S | 46.60 | 1,800 | 83,880 | 35,128 | 36.9 K to 35.1 K (-4.87 %) |
| Feb 29 2008 | PPDI | PHARMACEUTICAL PRO ... | COVINGTON PAUL S | Executive Vice Pres ... | Buy | M | 33.61 | 10,000 | 336,100 | 36,928 | 26.9 K to 36.9 K (+37.14 %) |
| Feb 29 2008 | PPDI | PHARMACEUTICAL PRO ... | COVINGTON PAUL S | Executive Vice Pres ... | Buy | M | 34.61 | 26,666 | 922,910 | 26,928 | 262 to 26.9 K (+10,177.86 %) |
| Feb 28 2008 | PPDI | PHARMACEUTICAL PRO ... | COVINGTON PAUL S | Executive Vice Pres ... | Option Exercise | M | 21.19 | 25,000 | 529,750 | 25,000 | |
| Feb 28 2008 | PPDI | PHARMACEUTICAL PRO ... | COVINGTON PAUL S | Executive Vice Pres ... | Sell | S | 46.75 | 1,962 | 91,724 | 262 | 2.2 K to 262 (-88.22 %) |
| Feb 28 2008 | PPDI | PHARMACEUTICAL PRO ... | COVINGTON PAUL S | Executive Vice Pres ... | Sell | S | 46.78 | 500 | 23,390 | 2,224 | 2.7 K to 2.2 K (-18.36 %) |
| Feb 28 2008 | PPDI | PHARMACEUTICAL PRO ... | COVINGTON PAUL S | Executive Vice Pres ... | Sell | S | 46.82 | 1,000 | 46,820 | 2,724 | 3.7 K to 2.7 K (-26.85 %) |
| Feb 28 2008 | PPDI | PHARMACEUTICAL PRO ... | COVINGTON PAUL S | Executive Vice Pres ... | Sell | S | 46.80 | 738 | 34,538 | 3,724 | 4.5 K to 3.7 K (-16.54 %) |
| Feb 28 2008 | PPDI | PHARMACEUTICAL PRO ... | COVINGTON PAUL S | Executive Vice Pres ... | Sell | S | 46.93 | 1,500 | 70,395 | 4,462 | 6 K to 4.5 K (-25.16 %) |
| Feb 28 2008 | PPDI | PHARMACEUTICAL PRO ... | COVINGTON PAUL S | Executive Vice Pres ... | Sell | S | 47.01 | 300 | 14,103 | 5,962 | 6.3 K to 6 K (-4.79 %) |
| Feb 28 2008 | PPDI | PHARMACEUTICAL PRO ... | COVINGTON PAUL S | Executive Vice Pres ... | Sell | S | 47.00 | 3,500 | 164,500 | 6,262 | 9.8 K to 6.3 K (-35.85 %) |
| Feb 28 2008 | PPDI | PHARMACEUTICAL PRO ... | COVINGTON PAUL S | Executive Vice Pres ... | Sell | S | 47.05 | 5,500 | 258,775 | 9,762 | 15.3 K to 9.8 K (-36.04 %) |
| Feb 28 2008 | PPDI | PHARMACEUTICAL PRO ... | COVINGTON PAUL S | Executive Vice Pres ... | Sell | S | 47.10 | 1,600 | 75,360 | 15,262 | 16.9 K to 15.3 K (-9.49 %) |
| Feb 28 2008 | PPDI | PHARMACEUTICAL PRO ... | COVINGTON PAUL S | Executive Vice Pres ... | Sell | S | 47.11 | 8,400 | 395,724 | 16,862 | 25.3 K to 16.9 K (-33.25 %) |
| Feb 28 2008 | PPDI | PHARMACEUTICAL PRO ... | COVINGTON PAUL S | Executive Vice Pres ... | Buy | M | 21.19 | 25,000 | 529,750 | 25,262 | 262 to 25.3 K (+9,541.98 %) |
| Jan 04 2008 | PPDI | PHARMACEUTICAL PRO ... | COVINGTON PAUL S | Executive Vice Pres ... | Buy | I | 34.44 | 262 | 9,023 | 262 | 0 to 262 |
| Aug 29 2007 | PPDI | PHARMACEUTICAL PRO ... | COVINGTON PAUL S | Executive Vice Pres ... | Sell | S | 35.09 | 9,045 | 317,389 | 0 | 9 K to 0 (-100.00 %) |
| Jul 05 2007 | PPDI | PHARMACEUTICAL PRO ... | COVINGTON PAUL S | Executive Vice Pres ... | Buy | I | 29.00 | 261 | 7,569 | 9,042 | 8.8 K to 9 K (+2.97 %) |
| May 30 2007 | PPDI | PHARMACEUTICAL PRO ... | COVINGTON PAUL S | Executive Vice Pres ... | Option Exercise | M | 21.19 | 25,000 | 529,750 | 50,000 | |
| May 30 2007 | PPDI | PHARMACEUTICAL PRO ... | COVINGTON PAUL S | Executive Vice Pres ... | Option Exercise | M | 15.30 | 13,334 | 204,010 | 0 | |
| May 30 2007 | PPDI | PHARMACEUTICAL PRO ... | COVINGTON PAUL S | Executive Vice Pres ... | Sell | S | 35.26 | 2,600 | 91,676 | 8,781 | 11.4 K to 8.8 K (-22.85 %) |
| May 30 2007 | PPDI | PHARMACEUTICAL PRO ... | COVINGTON PAUL S | Executive Vice Pres ... | Sell | S | 35.28 | 1,200 | 42,336 | 11,381 | 12.6 K to 11.4 K (-9.54 %) |
| May 30 2007 | PPDI | PHARMACEUTICAL PRO ... | COVINGTON PAUL S | Executive Vice Pres ... | Sell | S | 35.27 | 2,800 | 98,756 | 12,581 | 15.4 K to 12.6 K (-18.20 %) |
| May 30 2007 | PPDI | PHARMACEUTICAL PRO ... | COVINGTON PAUL S | Executive Vice Pres ... | Sell | S | 35.24 | 2,800 | 98,672 | 15,381 | 18.2 K to 15.4 K (-15.40 %) |
| May 30 2007 | PPDI | PHARMACEUTICAL PRO ... | COVINGTON PAUL S | Executive Vice Pres ... | Sell | S | 35.23 | 2,800 | 98,644 | 18,181 | 21 K to 18.2 K (-13.35 %) |
| May 30 2007 | PPDI | PHARMACEUTICAL PRO ... | COVINGTON PAUL S | Executive Vice Pres ... | Sell | S | 35.21 | 2,800 | 98,588 | 20,981 | 23.8 K to 21 K (-11.77 %) |
| May 30 2007 | PPDI | PHARMACEUTICAL PRO ... | COVINGTON PAUL S | Executive Vice Pres ... | Sell | S | 35.20 | 10,000 | 352,000 | 23,781 | 33.8 K to 23.8 K (-29.60 %) |
| May 30 2007 | PPDI | PHARMACEUTICAL PRO ... | COVINGTON PAUL S | Executive Vice Pres ... | Sell | S | 35.11 | 13,334 | 468,157 | 33,781 | 47.1 K to 33.8 K (-28.30 %) |
| May 30 2007 | PPDI | PHARMACEUTICAL PRO ... | COVINGTON PAUL S | Executive Vice Pres ... | Buy | M | 21.19 | 25,000 | 529,750 | 47,115 | 22.1 K to 47.1 K (+113.05 %) |
| May 30 2007 | PPDI | PHARMACEUTICAL PRO ... | COVINGTON PAUL S | Executive Vice Pres ... | Buy | M | 15.30 | 13,334 | 204,010 | 22,115 | 8.8 K to 22.1 K (+151.85 %) |
| May 30 2007 | PPDI | PHARMACEUTICAL PRO ... | COVINGTON PAUL S | Executive Vice Pres ... | Sell | S | 35.13 | 1,050 | 36,887 | 8,781 | 9.8 K to 8.8 K (-10.68 %) |
| May 30 2007 | PPDI | PHARMACEUTICAL PRO ... | COVINGTON PAUL S | Executive Vice Pres ... | Sell | S | 35.14 | 700 | 24,598 | 9,831 | 10.5 K to 9.8 K (-6.65 %) |
| Feb 23 2007 | PPDI | PHARMACEUTICAL PRO ... | COVINGTON PAUL S | Executive Vice Pres ... | Option Exercise | A | 33.61 | 30,000 | 1,008,300 | 30,000 | |
| Jan 04 2007 | PPDI | PHARMACEUTICAL PRO ... | COVINGTON PAUL S | Executive Vice Pres ... | Buy | I | 29.00 | 312 | 9,048 | 10,531 | 10.2 K to 10.5 K (+3.05 %) |
| Jul 07 2006 | PPDI | PHARMACEUTICAL PRO ... | COVINGTON PAUL S | Executive Vice Pres ... | Buy | I | 27.87 | 313 | 8,723 | 10,219 | 9.9 K to 10.2 K (+3.16 %) |
| Feb 24 2006 | PPDI | PHARMACEUTICAL PRO ... | COVINGTON PAUL S | Executive Vice Pres ... | Option Exercise | M | 42.38 | 12,500 | 529,750 | 64,167 | |
| Feb 24 2006 | PPDI | PHARMACEUTICAL PRO ... | COVINGTON PAUL S | Executive Vice Pres ... | Option Exercise | M | 30.60 | 6,667 | 204,010 | 76,667 | |
| Feb 24 2006 | PPDI | PHARMACEUTICAL PRO ... | COVINGTON PAUL S | Executive Vice Pres ... | Option Exercise | M | 29.89 | 6,667 | 199,277 | 83,334 | |
| Feb 24 2006 | PPDI | PHARMACEUTICAL PRO ... | COVINGTON PAUL S | Executive Vice Pres ... | Sell | S | 69.30 | 11,500 | 796,950 | 4,953 | 16.5 K to 5 K (-69.90 %) |
| Feb 24 2006 | PPDI | PHARMACEUTICAL PRO ... | COVINGTON PAUL S | Executive Vice Pres ... | Sell | S | 69.50 | 1,000 | 69,500 | 16,453 | 17.5 K to 16.5 K (-5.73 %) |
| Feb 24 2006 | PPDI | PHARMACEUTICAL PRO ... | COVINGTON PAUL S | Executive Vice Pres ... | Sell | S | 69.35 | 6,667 | 462,356 | 17,453 | 24.1 K to 17.5 K (-27.64 %) |
| Feb 24 2006 | PPDI | PHARMACEUTICAL PRO ... | COVINGTON PAUL S | Executive Vice Pres ... | Sell | S | 69.30 | 6,667 | 462,023 | 24,120 | 30.8 K to 24.1 K (-21.66 %) |
| Feb 24 2006 | PPDI | PHARMACEUTICAL PRO ... | COVINGTON PAUL S | Executive Vice Pres ... | Buy | M | 42.38 | 12,500 | 529,750 | 30,787 | 18.3 K to 30.8 K (+68.35 %) |
| Feb 24 2006 | PPDI | PHARMACEUTICAL PRO ... | COVINGTON PAUL S | Executive Vice Pres ... | Buy | M | 30.60 | 6,667 | 204,010 | 18,287 | 11.6 K to 18.3 K (+57.38 %) |
| Feb 24 2006 | PPDI | PHARMACEUTICAL PRO ... | COVINGTON PAUL S | Executive Vice Pres ... | Buy | M | 29.89 | 6,667 | 199,277 | 11,620 | 5 K to 11.6 K (+134.61 %) |
| Feb 23 2006 | PPDI | PHARMACEUTICAL PRO ... | COVINGTON PAUL S | Executive Vice Pres ... | Option Exercise | A | 69.23 | 20,000 | 1,384,600 | 90,001 | |
| Jan 04 2006 | PPDI | PHARMACEUTICAL PRO ... | COVINGTON PAUL S | Executive Vice Pres ... | Buy | I | 40.12 | 77 | 3,089 | 4,953 | 4.9 K to 5 K (+1.58 %) |
| Aug 24 2005 | PPDI | PHARMACEUTICAL PRO ... | COVINGTON PAUL S | Executive Vice Pres ... | Option Exercise | M | 30.10 | 15,000 | 451,500 | 70,001 | |
| Aug 24 2005 | PPDI | PHARMACEUTICAL PRO ... | COVINGTON PAUL S | Executive Vice Pres ... | Option Exercise | M | 26.22 | 15,000 | 393,300 | 85,001 | |
| Aug 24 2005 | PPDI | PHARMACEUTICAL PRO ... | COVINGTON PAUL S | Executive Vice Pres ... | Option Exercise | M | 18.63 | 20,000 | 372,600 | 100,001 | |
| Aug 24 2005 | PPDI | PHARMACEUTICAL PRO ... | COVINGTON PAUL S | Executive Vice Pres ... | Sell | S | 55.42 | 747 | 41,399 | 4,876 | 5.6 K to 4.9 K (-13.28 %) |
| Aug 24 2005 | PPDI | PHARMACEUTICAL PRO ... | COVINGTON PAUL S | Executive Vice Pres ... | Sell | S | 55.40 | 9,253 | 512,616 | 5,623 | 14.9 K to 5.6 K (-62.20 %) |
| Aug 24 2005 | PPDI | PHARMACEUTICAL PRO ... | COVINGTON PAUL S | Executive Vice Pres ... | Sell | S | 54.77 | 493 | 27,002 | 14,876 | 15.4 K to 14.9 K (-3.21 %) |
| Aug 24 2005 | PPDI | PHARMACEUTICAL PRO ... | COVINGTON PAUL S | Executive Vice Pres ... | Sell | S | 54.76 | 1,100 | 60,236 | 15,369 | 16.5 K to 15.4 K (-6.68 %) |
| Aug 24 2005 | PPDI | PHARMACEUTICAL PRO ... | COVINGTON PAUL S | Executive Vice Pres ... | Sell | S | 54.75 | 3,407 | 186,533 | 16,469 | 19.9 K to 16.5 K (-17.14 %) |
| Aug 24 2005 | PPDI | PHARMACEUTICAL PRO ... | COVINGTON PAUL S | Executive Vice Pres ... | Sell | S | 55.33 | 100 | 5,533 | 19,876 | 20 K to 19.9 K (-0.50 %) |
| Aug 24 2005 | PPDI | PHARMACEUTICAL PRO ... | COVINGTON PAUL S | Executive Vice Pres ... | Sell | S | 55.32 | 9,900 | 547,668 | 19,976 | 29.9 K to 20 K (-33.14 %) |
| Aug 24 2005 | PPDI | PHARMACEUTICAL PRO ... | COVINGTON PAUL S | Executive Vice Pres ... | Sell | S | 54.67 | 2,900 | 158,543 | 29,876 | 32.8 K to 29.9 K (-8.85 %) |
| Aug 24 2005 | PPDI | PHARMACEUTICAL PRO ... | COVINGTON PAUL S | Executive Vice Pres ... | Sell | S | 54.66 | 1,900 | 103,854 | 32,776 | 34.7 K to 32.8 K (-5.48 %) |
| Aug 24 2005 | PPDI | PHARMACEUTICAL PRO ... | COVINGTON PAUL S | Executive Vice Pres ... | Sell | S | 54.65 | 200 | 10,930 | 34,676 | 34.9 K to 34.7 K (-0.57 %) |
| Aug 24 2005 | PPDI | PHARMACEUTICAL PRO ... | COVINGTON PAUL S | Executive Vice Pres ... | Sell | S | 55.04 | 485 | 26,694 | 34,876 | 35.4 K to 34.9 K (-1.37 %) |
| Aug 24 2005 | PPDI | PHARMACEUTICAL PRO ... | COVINGTON PAUL S | Executive Vice Pres ... | Sell | S | 55.03 | 700 | 38,521 | 35,361 | 36.1 K to 35.4 K (-1.94 %) |
| Aug 24 2005 | PPDI | PHARMACEUTICAL PRO ... | COVINGTON PAUL S | Executive Vice Pres ... | Sell | S | 55.01 | 715 | 39,332 | 36,061 | 36.8 K to 36.1 K (-1.94 %) |
| Aug 24 2005 | PPDI | PHARMACEUTICAL PRO ... | COVINGTON PAUL S | Executive Vice Pres ... | Sell | S | 55.00 | 3,500 | 192,500 | 36,776 | 40.3 K to 36.8 K (-8.69 %) |
| Aug 24 2005 | PPDI | PHARMACEUTICAL PRO ... | COVINGTON PAUL S | Executive Vice Pres ... | Sell | S | 55.53 | 300 | 16,659 | 40,276 | 40.6 K to 40.3 K (-0.74 %) |
| Aug 24 2005 | PPDI | PHARMACEUTICAL PRO ... | COVINGTON PAUL S | Executive Vice Pres ... | Sell | S | 55.51 | 500 | 27,755 | 40,576 | 41.1 K to 40.6 K (-1.22 %) |
| Aug 24 2005 | PPDI | PHARMACEUTICAL PRO ... | COVINGTON PAUL S | Executive Vice Pres ... | Sell | S | 55.50 | 700 | 38,850 | 41,076 | 41.8 K to 41.1 K (-1.68 %) |
| Aug 24 2005 | PPDI | PHARMACEUTICAL PRO ... | COVINGTON PAUL S | Executive Vice Pres ... | Sell | S | 55.44 | 300 | 16,632 | 41,776 | 42.1 K to 41.8 K (-0.71 %) |
| Aug 24 2005 | PPDI | PHARMACEUTICAL PRO ... | COVINGTON PAUL S | Executive Vice Pres ... | Sell | S | 55.43 | 200 | 11,086 | 42,076 | 42.3 K to 42.1 K (-0.47 %) |
| Aug 24 2005 | PPDI | PHARMACEUTICAL PRO ... | COVINGTON PAUL S | Executive Vice Pres ... | Sell | S | 55.41 | 4,500 | 249,345 | 42,276 | 46.8 K to 42.3 K (-9.62 %) |
| Aug 24 2005 | PPDI | PHARMACEUTICAL PRO ... | COVINGTON PAUL S | Executive Vice Pres ... | Sell | S | 55.32 | 2,400 | 132,768 | 46,776 | 49.2 K to 46.8 K (-4.88 %) |
| Aug 24 2005 | PPDI | PHARMACEUTICAL PRO ... | COVINGTON PAUL S | Executive Vice Pres ... | Sell | S | 55.30 | 5,700 | 315,210 | 49,176 | 54.9 K to 49.2 K (-10.39 %) |
| Aug 24 2005 | PPDI | PHARMACEUTICAL PRO ... | COVINGTON PAUL S | Executive Vice Pres ... | Buy | M | 30.10 | 15,000 | 451,500 | 54,876 | 39.9 K to 54.9 K (+37.62 %) |
| Aug 24 2005 | PPDI | PHARMACEUTICAL PRO ... | COVINGTON PAUL S | Executive Vice Pres ... | Buy | M | 26.22 | 15,000 | 393,300 | 39,876 | 24.9 K to 39.9 K (+60.30 %) |
| Aug 24 2005 | PPDI | PHARMACEUTICAL PRO ... | COVINGTON PAUL S | Executive Vice Pres ... | Buy | M | 18.63 | 20,000 | 372,600 | 24,876 | 4.9 K to 24.9 K (+410.17 %) |
| Aug 23 2005 | PPDI | PHARMACEUTICAL PRO ... | COVINGTON PAUL S | Executive Vice Pres ... | Option Exercise | M | 30.60 | 6,666 | 203,980 | 120,001 | |
| Aug 23 2005 | PPDI | PHARMACEUTICAL PRO ... | COVINGTON PAUL S | Executive Vice Pres ... | Option Exercise | M | 29.89 | 6,667 | 199,277 | 126,667 | |
| Aug 23 2005 | PPDI | PHARMACEUTICAL PRO ... | COVINGTON PAUL S | Executive Vice Pres ... | Sell | S | 54.82 | 1,456 | 79,818 | 4,876 | 6.3 K to 4.9 K (-22.99 %) |
| Aug 23 2005 | PPDI | PHARMACEUTICAL PRO ... | COVINGTON PAUL S | Executive Vice Pres ... | Sell | S | 55.45 | 5,111 | 283,405 | 6,332 | 11.4 K to 6.3 K (-44.66 %) |
| Aug 23 2005 | PPDI | PHARMACEUTICAL PRO ... | COVINGTON PAUL S | Executive Vice Pres ... | Sell | S | 55.65 | 100 | 5,565 | 11,443 | 11.5 K to 11.4 K (-0.87 %) |
| Aug 23 2005 | PPDI | PHARMACEUTICAL PRO ... | COVINGTON PAUL S | Executive Vice Pres ... | Sell | S | 55.70 | 6,666 | 371,296 | 11,543 | 18.2 K to 11.5 K (-36.61 %) |
| Aug 23 2005 | PPDI | PHARMACEUTICAL PRO ... | COVINGTON PAUL S | Executive Vice Pres ... | Buy | M | 29.89 | 6,667 | 199,277 | 18,209 | 11.5 K to 18.2 K (+57.76 %) |
| Aug 23 2005 | PPDI | PHARMACEUTICAL PRO ... | COVINGTON PAUL S | Executive Vice Pres ... | Buy | M | 30.60 | 6,666 | 203,980 | 11,542 | 4.9 K to 11.5 K (+136.71 %) |
| Jul 08 2005 | PPDI | PHARMACEUTICAL PRO ... | COVINGTON PAUL S | Executive Vice Pres ... | Buy | I | 35.10 | 179 | 6,283 | 4,876 | 4.7 K to 4.9 K (+3.81 %) |
| Jan 03 2005 | PPDI | PHARMACEUTICAL PRO ... | COVINGTON PAUL S | Executive Vice Pres ... | Buy | I | 31.56 | 112 | 3,535 | 4,697 | 4.6 K to 4.7 K (+2.44 %) |
| Jan 03 2005 | PPDI | PHARMACEUTICAL PRO ... | COVINGTON PAUL S | Executive Vice Pres ... | Gift | G | 0.00 | 375 | 0 | 4,585 | 5 K to 4.6 K (-7.56 %) |
| Nov 17 2004 | PPDI | PHARMACEUTICAL PRO ... | COVINGTON PAUL S | Executive Vice Pres ... | Option Exercise | A | 42.38 | 50,000 | 2,119,000 | 133,334 | |
| Nov 15 2004 | PPDI | PHARMACEUTICAL PRO ... | COVINGTON PAUL S | Executive Vice Pres ... | Option Exercise | M | 29.89 | 6,666 | 199,247 | 83,334 | |
| Nov 15 2004 | PPDI | PHARMACEUTICAL PRO ... | COVINGTON PAUL S | Executive Vice Pres ... | Option Exercise | M | 6.53 | 13,334 | 87,071 | 90,000 | |
| Nov 15 2004 | PPDI | PHARMACEUTICAL PRO ... | COVINGTON PAUL S | Executive Vice Pres ... | Option Exercise | M | 14.00 | 6,668 | 93,352 | 103,334 | |
| Nov 15 2004 | PPDI | PHARMACEUTICAL PRO ... | COVINGTON PAUL S | Executive Vice Pres ... | Sell | S | 42.25 | 16,668 | 704,223 | 4,960 | 21.6 K to 5 K (-77.07 %) |
| Nov 15 2004 | PPDI | PHARMACEUTICAL PRO ... | COVINGTON PAUL S | Executive Vice Pres ... | Sell | S | 42.26 | 5,000 | 211,300 | 21,628 | 26.6 K to 21.6 K (-18.78 %) |
| Nov 15 2004 | PPDI | PHARMACEUTICAL PRO ... | COVINGTON PAUL S | Executive Vice Pres ... | Sell | S | 42.40 | 5,000 | 212,000 | 26,628 | 31.6 K to 26.6 K (-15.81 %) |
| Nov 15 2004 | PPDI | PHARMACEUTICAL PRO ... | COVINGTON PAUL S | Executive Vice Pres ... | Buy | M | 29.89 | 6,666 | 199,247 | 31,628 | 25 K to 31.6 K (+26.70 %) |
| Nov 15 2004 | PPDI | PHARMACEUTICAL PRO ... | COVINGTON PAUL S | Executive Vice Pres ... | Buy | M | 6.53 | 13,334 | 87,071 | 24,962 | 11.6 K to 25 K (+114.67 %) |
| Nov 15 2004 | PPDI | PHARMACEUTICAL PRO ... | COVINGTON PAUL S | Executive Vice Pres ... | Buy | M | 14.00 | 6,668 | 93,352 | 11,628 | 5 K to 11.6 K (+134.44 %) |
| Jul 01 2004 | PPDI | PHARMACEUTICAL PRO ... | COVINGTON PAUL S | Executive Vice Pres ... | Buy | I | 22.92 | 128 | 2,934 | 4,960 | 4.8 K to 5 K (+2.65 %) |
| May 24 2004 | PPDI | PHARMACEUTICAL PRO ... | COVINGTON PAUL S | Executive Vice Pres ... | Sell | S | 30.17 | 4,400 | 132,748 | 4,832 | 9.2 K to 4.8 K (-47.66 %) |
| May 24 2004 | PPDI | PHARMACEUTICAL PRO ... | COVINGTON PAUL S | Executive Vice Pres ... | Sell | S | 29.86 | 866 | 25,859 | 9,232 | 10.1 K to 9.2 K (-8.58 %) |
| May 24 2004 | PPDI | PHARMACEUTICAL PRO ... | COVINGTON PAUL S | Executive Vice Pres ... | Sell | S | 30.07 | 1,100 | 33,077 | 10,098 | 11.2 K to 10.1 K (-9.82 %) |
| May 24 2004 | PPDI | PHARMACEUTICAL PRO ... | COVINGTON PAUL S | Executive Vice Pres ... | Sell | S | 29.95 | 2,000 | 59,900 | 11,198 | 13.2 K to 11.2 K (-15.15 %) |
| May 24 2004 | PPDI | PHARMACEUTICAL PRO ... | COVINGTON PAUL S | Executive Vice Pres ... | Sell | S | 30.17 | 4,400 | 132,748 | 4,832 | 9.2 K to 4.8 K (-47.66 %) |
| May 24 2004 | PPDI | PHARMACEUTICAL PRO ... | COVINGTON PAUL S | Executive Vice Pres ... | Sell | S | 29.86 | 866 | 25,859 | 9,232 | 10.1 K to 9.2 K (-8.58 %) |
| May 24 2004 | PPDI | PHARMACEUTICAL PRO ... | COVINGTON PAUL S | Executive Vice Pres ... | Sell | S | 30.07 | 1,100 | 33,077 | 10,098 | 11.2 K to 10.1 K (-9.82 %) |
| May 24 2004 | PPDI | PHARMACEUTICAL PRO ... | COVINGTON PAUL S | Executive Vice Pres ... | Sell | S | 29.95 | 2,000 | 59,900 | 11,198 | 13.2 K to 11.2 K (-15.15 %) |
Page: 1